Pancreatic Cancer Research

ResearcherDalian Medical UniversityActive in the last 2 years

Dong Shang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-2488-5503; OpenAlex author ID A5108630127. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 3 papers

Papers 7

  1. A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2023.09.050↗
  2. Letter to the editor ‘Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection’ First author DOI 10.1097/js9.0000000000001555↗
  3. Identification of basement membrane-related prognostic model associated with the immune microenvironment and synthetic therapy response in pancreatic cancer: i… Last author DOI 10.7150/jca.100891↗
  4. A prospective prognostic signature for pancreatic adenocarcinoma based on ubiquitination-related mRNA-lncRNA with experimental validation in vitro and vivo. Last author DOI 10.1007/s10142-023-01158-1↗
  5. Characterization of neuroendocrine regulation- and metabolism-associated molecular features and prognostic indicators with aid to clinical chemotherapy and imm… Last author DOI 10.3389/fendo.2022.1078424↗
  6. Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer. Co-author DOI 10.3389/fonc.2022.991051↗
  7. DOK1/3/6 Serve as Potential Prognostic Biomarkers and Immunotherapy Targets for Pancreatic Cancer Last author DOI 10.21203/rs.3.rs-907920/v1↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qihang Yuan · 3 shared papers, 2022–2024 · strength 0.80
  2. Biao Zhang · 2 shared papers, 2022–2024 · strength 0.37
  3. Zhizhou Wang · 2 shared papers, 2022–2023 · strength 0.34
  4. Xu Chen · 2 shared papers, 2022–2023 · strength 0.34
  5. Fangyue Guo · 2 shared papers, 2021–2023 · strength 0.33
  6. Huiyi Song · 1 shared paper, 2024 · strength 0.22
  7. Shilin Xia · 1 shared paper, 2024 · strength 0.22
  8. John S. Bolton · 1 shared paper, 2024 · strength 0.20
  9. Caiming Xu · 1 shared paper, 2024 · strength 0.20
  10. Eunsung Jun · 1 shared paper, 2024 · strength 0.20
  11. Guixin Zhang · 1 shared paper, 2024 · strength 0.20
  12. Akinobu Taketomi · 1 shared paper, 2024 · strength 0.20
  13. Erkut Hasan Borazanci · 1 shared paper, 2024 · strength 0.20
  14. Ajay Goel · 1 shared paper, 2024 · strength 0.20
  15. Song Cheol Kim · 1 shared paper, 2024 · strength 0.20
  16. Daniel D. Von Hoff · 1 shared paper, 2024 · strength 0.20
  17. Xueying Shi · 1 shared paper, 2023 · strength 0.18
  18. Shuang Li · 1 shared paper, 2022 · strength 0.16
  19. Hangyu Liu · 1 shared paper, 2022 · strength 0.16
  20. Dawei Deng · 1 shared paper, 2021 · strength 0.15
  21. Jiwei Liu · 1 shared paper, 2022 · strength 0.15
  22. Chang Liu · 1 shared paper, 2022 · strength 0.15
  23. Aman Wang · 1 shared paper, 2022 · strength 0.15
  24. Haihua Liu · 1 shared paper, 2022 · strength 0.15
  25. Henan Qin · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.